Glycopyrronium Bromide Morningside Healthcare (Glycopyrronium Bromide)

Glycopyrronium bromide is primarily employed as a bronchodilator in the management of respiratory disorders where airway constriction is a component.

• Adjunct therapy for chronic obstructive pulmonary disease (COPD) to improve airflow.
• Maintenance treatment for asthma when anticholinergic action is indicated.
• Pre‑operative medication to reduce airway secretions during anesthesia.
• Management of hyperhidrosis (excessive sweating) in patients for whom topical agents are insufficient.

The safety profile of glycopyrronium bromide includes both frequently observed and less common adverse reactions.

Common

• Dry mouth.
• Constipation.
• Urinary retention.
• Blurred vision.
• Headache.

Serious

• Severe bronchospasm.
• Acute angle‑closure glaucoma.
• Cardiac arrhythmias.
• Allergic reactions such as rash or angioedema.

Before initiating therapy with glycopyrronium bromide, clinicians should consider several precautionary factors to ensure safe use.

• Assess for a history of narrow‑angle glaucoma or intra‑ocular pressure disorders.
• Evaluate urinary tract obstruction or prostate enlargement that could worsen retention.
• Use cautiously in patients with severe cardiovascular disease or tachyarrhythmias.
• Monitor for anticholinergic burden in elderly individuals or those on multiple anticholinergic drugs.
• Avoid use in patients with known hypersensitivity to glycopyrronium or related compounds.
• Consider dose adjustment in hepatic impairment, as metabolism may be reduced.

Glycopyrronium bromide may interact with other medications, altering its efficacy or increasing adverse effects.

Avoid

• Other anticholinergic agents (e.g., atropine, ipratropium) due to additive anticholinergic effects.
• Potent CYP3A4 inhibitors if the formulation involves hepatic metabolism.

Use with caution

• Beta‑agonist bronchodilators, as combined therapy may affect heart rate.
• Drugs that prolong QT interval, such as certain antiarrhythmics.
• Medications that increase intra‑ocular pressure, like corticosteroid eye drops.
• Diuretics, because of potential electrolyte disturbances.